BIOFAC A/S: Financial statements 2023
CVR: 62550511
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
BIOFAC A/S (CVR 62550511) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 37,268,257 and a net result of DKK 1,609,606 compared with DKK -5,952,699 the year before. That is an increase of 83.7% compared with the year before. Equity in the 2023 report amounted to DKK 14,253,752. The solvency ratio was 9.1%. The company had 73 employees in the financial year.
- Gross Profit
- DKK 37,268,257
- Profit/Loss
- DKK 1,609,606
- Equity
- DKK 14,253,752
- Total Assets
- DKK 156,735,628
- Employees
- 73
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 37.3 mio. | 1.6 mio. | 14.3 mio. | 73 |
| 2022 | - | 20.3 mio. | -6 mio. | 12.6 mio. | 76 |
| 2021 | - | 28.8 mio. | -1.1 mio. | 18.6 mio. | 71 |
| 2020 | - | 23.4 mio. | -4.2 mio. | 19.7 mio. | 68 |
| 2019 | - | 14.4 mio. | -7.9 mio. | 23.9 mio. | 71 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout BIOFAC A/S
BIOFAC A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1934. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Helle Rørvig, Niels Ulrik Heine and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 83 employees (2026). In 2025, the company reported a gross profit of DKK 73,647,426 and a net result of DKK -3,775,890 compared with DKK 332,520 the year before. Equity in the 2025 report amounted to DKK 10,810,382.